The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo

BMC Medicine

Volumn 8, Issue , 2010, Pages

  Fleming, Jodie M ^a   Miller, Tyler C ^a   Quinones, Mariam ^b   Xiao, Zhen ^c   Xu, Xia ^c   Meyer, Matthew J ^a   Ginsburg, Erika ^a   Veenstra, Timothy D ^c   Vonderhaar, Barbara K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRONE; CELL PROTEIN; CYTOKINE; ESTRADIOL; ESTRIOL; ESTROGEN RECEPTOR; HORMONE; PROGESTERONE RECEPTOR; PROTEINASE;

ADULT; AFRICAN AMERICAN; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER SIZE; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CAUCASIAN; CELL FUNCTION; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; METABOLITE; METASTASIS; METASTASIS POTENTIAL; MICROENVIRONMENT; MOUSE; NONHUMAN; PREMENOPAUSE; PROTEIN EXPRESSION; TISSUE STRUCTURE; TUMOR XENOGRAFT; ANIMAL; BREAST; BREAST TUMOR; CHEMISTRY; DISEASE MODEL; DRUG SCREENING; ETHNOLOGY; IMMUNOLOGY; MASS SPECTROMETRY; MIDDLE AGED; PHYSIOLOGY; TUMOR CELL LINE; UNITED STATES; XENOGRAFT;

ADULT; AFRICAN AMERICANS; ANIMALS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MASS SPECTROMETRY; MICE; MIDDLE AGED; PREMENOPAUSE; TRANSPLANTATION, HETEROLOGOUS; UNITED STATES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77952464565     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-8-27     Document Type: Article

References (57)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007, 57:43-66. 10.3322/canjclin.57.1.43, 17237035.
2. Dong-Le Bourhis X, Berthois Y, Millot G, Degeorges A, Sylvi M, Martin PM, Calvo F. Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int J Cancer 1997, 71:42-48. 10.1002/(SICI)1097-0215(19970328)71:1<42::AID-IJC9>3.0.CO;2-3, 9096664.
3. Sadlonova A, Novak Z, Johnson MR, Bowe DB, Gault SR, Page GP, Thottassery JV, Welch DR, Frost AR. Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture. Breast Cancer Res 2005, 7:R46-59. 10.1186/bcr949, 1064098, 15642169.
4. Shekhar MP, Werdell J, Santner SJ, Pauley RJ, Tait L. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res 2001, 61:1320-1326.
5. van Roozendaal KE, Klijn JG, van Ooijen B, Claassen C, Eggermont AM, Henzen-Logmans SC, Foekens JA. Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources. Int J Cancer 1996, 65:120-125. 10.1002/(SICI)1097-0215(19960103)65:1<120::AID-IJC20>3.0.CO;2-J, 8543388.
6. Barcellos-Hoff MH, Ravani SA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 2000, 60:1254-1260.
7. Proia DA, Kuperwasser C. Stroma: tumor agonist or antagonist. Cell Cycle 2005, 4:1022-1025.
8. Sadlonova A, Mukherjee S, Bowe DB, Gault SR, Dumas NA, Van Tine BA, Frolova N, Page GP, Welch DR, Novak L, Frost AR. Human breast fibroblasts inhibit growth of the MCF10AT xenograft model of proliferative breast disease. Am J Pathol 2007, 170:1064-1076. 10.2353/ajpath.2007.060031, 1864888, 17322389.
9. Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, Richardson A, Violette S, Nikolskaya T, Nikolsky Y, Bauerlein EL, Hahn WC, Gelman RS, Allred C, Bissell MJ, Schnitt S, Polyak K. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008, 13:394-406. 10.1016/j.ccr.2008.03.007, 18455123.
10. Booth BW, Mack DL, Androutsellis-Theotokis A, McKay RD, Boulanger CA, Smith GH. The mammary microenvironment alters the differentiation repertoire of neural stem cells. Proc Natl Acad Sci USA 2008, 105:14891-14896. 10.1073/pnas.0803214105, 2567463, 18809919.
11. Boulanger CA, Mack DL, Booth BW, Smith GH. Interaction with the mammary microenvironment redirects spermatogenic cell fate in vivo. Proc Natl Acad Sci USA 2007, 104:3871-3876. 10.1073/pnas.0611637104, 1820676, 17360445.
12. Parise CA, Bauer KR, Brown MM, Caggiano V. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004. Breast J 2009, 15:593-602. 10.1111/j.1524-4741.2009.00822.x, 19764994.
13. Brown M, Tsodikov A, Bauer KR, Parise CA, Caggiano V. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004. Cancer 2008, 112:737-747. 10.1002/cncr.23243, 18189290.
14. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 2007, 109:1721-1728. 10.1002/cncr.22618, 17387718.
15. Parise CA, Bauer KR, Caggiano V. Variation in breast cancer subtypes with age and race/ethnicity. Crit Rev Oncol Hematol
16. Hunter CP. Epidemiology, stage at diagnosis, and tumor biology of breast carcinoma in multiracial and multiethnic populations. Cancer 2000, 88:1193-1202. 10.1002/(SICI)1097-0142(20000301)88:5+<1193::AID-CNCR3>3.0.CO;2-D, 10705354.
17. Rose DP, Haffner SM, Baillargeon J. Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev 2007, 28:763-777. 10.1210/er.2006-0019, 17981890.
18. Newman LA, Mason J, Cote D, Vin Y, Carolin K, Bouwman D, Colditz GA. African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 White American patients with carcinoma of the breast. Cancer 2002, 94:2844-2854. 10.1002/cncr.10575, 12115371.
19. Ijaduola TG, Smith EB. Pattern of breast cancer among white-American, African-American, and nonimmigrant west-African women. J Natl Med Assoc 1998, 90:547-551. 2568291, 9770955.
20. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100:3983-3988. 10.1073/pnas.0530291100, 153034, 12629218.
21. Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990, 50:6075-6086.
22. Mercier I, Casimiro MC, Wang C, Rosenberg AL, Quong J, Minkeu A, Allen KG, Danilo C, Sotgia F, Bonuccelli G, Jasmin JF, Xu H, Bosco E, Aronow B, Witkiewicz A, Pestell RG, Knudsen ES, Lisanti MP. Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: implications for the response to hormonal therapy. Cancer Biol Ther 2008, 7:1212-1225. 10.4161/cbt.7.8.6220, 18458534.
23. Schedin P, Mitrenga T, McDaniel S, Kaeck M. Mammary ECM composition and function are altered by reproductive state. Mol Carcinog 2004, 41:207-220. 10.1002/mc.20058, 15468292.
24. Fleming JM, Long EL, Ginsburg E, Gerscovich D, Meltzer PS, Vonderhaar BK. Interlobular and intralobular mammary stroma: genotype may not reflect phenotype. BMC Cell Biol 2008, 9:46. 10.1186/1471-2121-9-46, 2529294, 18710550.
25. Proia DA, Kuperwasser C. Reconstruction of human mammary tissues in a mouse model. Nat Protoc 2006, 1:206-214. 10.1038/nprot.2006.31, 17406234.
26. McDaniel SM, Rumer KK, Biroc SL, Metz RP, Singh M, Porter W, Schedin P. Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. Am J Pathol 2006, 168:608-620. 10.2353/ajpath.2006.050677, 1606507, 16436674.
27. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, Richardson A, Weinberg RA. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 2004, 101:4966-4971. 10.1073/pnas.0401064101, 387357, 15051869.
28. Hu M, Polyak K. Molecular characterisation of the tumour microenvironment in breast cancer. Eur J Cancer 2008, 44:2760-2765. 10.1016/j.ejca.2008.09.038, 2729518, 19026532.
29. Stuelten CH, Barbul A, Busch JI, Sutton E, Katz R, Sato M, Wakefield LM, Roberts AB, Niederhuber JE. Acute wounds accelerate tumorigenesis by a T cell-dependent mechanism. Cancer Res 2008, 68:7278-7282. 10.1158/0008-5472.CAN-08-1842, 2766858, 18794114.
30. Nicolini A, Carpi A. Immune manipulation of advanced breast cancer: an interpretative model of the relationship between immune system and tumor cell biology. Med Res Rev 2009, 29:436-71. 10.1002/med.20143, 19105214.
31. Groblewska M, Mroczko B, Czygier M, Szmitkowski M. Cytokines as markers of osteolysis in the diagnostics of patients with bone metastases [in Polish]. Postepy Hig Med Dosw (Online) 2008, 62:668-675.
32. Ronnov-Jessen L, Bissell MJ. Breast cancer by proxy: can the microenvironment be both the cause and consequence?. Trends Mol Med 2009, 15:5-13. 10.1016/j.molmed.2008.11.001, 2746030, 19091631.
33. Brummer O, Athar S, Riethdorf L, Loning T, Herbst H. Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study. Virchows Arch 1999, 435:566-573. 10.1007/s004280050442, 10628798.
34. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997, 277:225-228. 10.1126/science.277.5323.225, 9211848.
35. Schedin P, Strange R, Mitrenga T, Wolfe P, Kaeck M. Fibronectin fragments induce MMP activity in mouse mammary epithelial cells: evidence for a role in mammary tissue remodeling. J Cell Sci 2000, 113:795-806.
36. Xiao Z, Blonder J, Zhou M, Veenstra TD. Proteomic analysis of extracellular matrix and vesicles. J Proteomics 2009, 72:34-45. 10.1016/j.jprot.2008.11.011, 19068243.
37. Stern DF. ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer. J Mammary Gland Biol Neoplasia 2008, 13:215-223. 10.1007/s10911-008-9083-7, 18454306.
38. Zardawi SJ, O'Toole SA, Sutherland RL, Musgrove EA. Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. Histol Histopathol 2009, 24:385-398.
39. Kronenberg H, Williams RH. Williams textbook of endocrinology 2008, Philadelphia, PA, USA: Saunders/Elsevier, 11.
40. Pinheiro SP, Holmes MD, Pollak MN, Barbieri RL, Hankinson SE. Racial differences in premenopausal endogenous hormones. Cancer Epidemiol Biomarkers Prev 2005, 14:2147-2153. 10.1158/1055-9965.EPI-04-0944, 16172224.
41. Woods MN, Barnett JB, Spiegelman D, Trail N, Hertzmark E, Longcope C, Gorbach SL. Hormone levels during dietary changes in premenopausal African-American women. J Natl Cancer Inst 1996, 88:1369-1374. 10.1093/jnci/88.19.1369, 8827014.
42. Ingber DE. Can cancer be reversed by engineering the tumor microenvironment?. Semin Cancer Biol 2008, 18:356-364. 10.1016/j.semcancer.2008.03.016, 2570051, 18472275.
43. Williams G, Anderson E, Howell A, Watson R, Coyne J, Roberts SA, Potten CS. Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer 1991, 48:206-210. 10.1002/ijc.2910480209, 2019467.
44. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D, Hammer DA, Weaver VM. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8:241-254. 10.1016/j.ccr.2005.08.010, 16169468.
45. Alcaraz J, Xu R, Mori H, Nelson CM, Mroue R, Spencer VA, Brownfield D, Radisky DC, Bustamante C, Bissell MJ. Laminin and biomimetic extracellular elasticity enhance functional differentiation in mammary epithelia. EMBO J 2008, 27:2829-2838. 10.1038/emboj.2008.206, 2569873, 18843297.
46. Barcellos-Hoff MH, Aggeler J, Ram TG, Bissell MJ. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development 1989, 105:223-235.
47. Grimshaw MJ, Cooper L, Papazisis K, Coleman JA, Bohnenkamp HR, Chiapero-Stanke L, Taylor-Papadimitriou J, Burchell JM. Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res 2008, 10:R52. 10.1186/bcr2106, 2481500, 18541018.
48. Reynolds BA, Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 1996, 175:1-13. 10.1006/dbio.1996.0090, 8608856.
49. Lin HY, Sun M, Lin C, Tang HY, London D, Shih A, Davis FB, Davis PJ. Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-alpha-positive and -negative breast cancer cells. J Steroid Biochem Mol Biol 2009, 113:182-188. 10.1016/j.jsbmb.2008.12.010, 19159686.
50. Rohwer N, Lobitz S, Daskalow K, Jons T, Vieth M, Schlag PM, Kemmner W, Wiedenmann B, Cramer T, Hocker M. HIF-1a determines the metastatic potential of gastric cancer cells. Br J Cancer 2009, 100:772-781. 10.1038/sj.bjc.6604919, 2653758, 19223895.
51. Gupta PB, Proia D, Cingoz O, Weremowicz J, Naber SP, Weinberg RA, Kuperwasser C. Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res 2007, 67:2062-2071. 10.1158/0008-5472.CAN-06-3895, 17332335.
52. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 2004, 91:1983-1989. 10.1038/sj.bjc.6602297, 2410148, 15599380.
53. Haslam SZ, Woodward TL. Host microenvironment in breast cancer development: epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland. Breast Cancer Res 2003, 5:208-215. 10.1186/bcr615, 165024, 12817994.
54. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL, . Prevention and Observation of Surgical End Points Study Group Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002, 346:1616-1622. 10.1056/NEJMoa012158, 12023993, Prevention and Observation of Surgical End Points Study Group.
55. Lyons TR, Schedin PJ, Borges VF. Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia 2009, 14:87-98. 10.1007/s10911-009-9119-7, 2693784, 19381788.
56. Mueck AO, Seeger H, Lippert TH. Estradiol metabolism and malignant disease. Maturitas 2002, 43:1-10. 10.1016/S0378-5122(02)00141-X, 12270576.
57. Suto A, Bradlow HL, Wong GY, Osborne MP, Telang NT. Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells. Breast Cancer Res Treat 1993, 27:193-202. 10.1007/BF00665689, 8312577.